Is BMY or LLY cheaper?

On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and LLY at 40.25.

Which has grown faster, BMY or LLY?

Over the past five years, LLY grew revenue faster — BMY at a 2.52% CAGR versus LLY at 23.17%.

Does BMY or LLY pay a bigger dividend?

BMY yields 4.38% and LLY yields 0.57% based on trailing dividends and the latest price.

Is BMY or LLY more profitable?

LLY runs the higher net margin — BMY at 15.01% versus LLY at 34.98%.

Which has been the better investment, BMY or LLY?

Over the past 10-year, LLY delivered the higher annualized total return — BMY at 1.08% versus LLY at 33.50%. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Eli Lilly and Company (LLY)

LLY leads on 10 of 17 compared metrics, though BMY is the cheaper stock.

A side-by-side comparison of Bristol-Myers Squibb Company and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BMY

Bristol-Myers Squibb Company

$116.66B

$57.13Healthcare

LLY

Eli Lilly and Company

$1.07T

$1133.00Healthcare

Total return — BMY vs LLY

growth of $100 · last 30y

BMY +171.1%LLY +3454.0%LLY compounded faster

Log scale — wide-divergence pair

BMY LLY

BMY vs LLY: by the numbers

•LLY is the larger company ($1.07T vs $116.66B market cap).
•BMY trades at the lower earnings multiple (16.05 vs 40.25 P/E).
•LLY converts more revenue to profit (34.98% vs 15.01% net margin).
•LLY grew revenue faster over the past five years (23.17% vs 2.52% CAGR).
•BMY pays the higher dividend yield (4.38% vs 0.57%).

Which is better, BMY or LLY?

Metric tally: BMY 7 · LLY 10

It depends on what you're optimizing for:

ValueBMY(lower P/E)

GrowthLLY(faster 5Y revenue CAGR)

IncomeBMY(higher dividend yield)

QualityLLY(higher ROIC)

Valuation

Metric	BMY	LLY
P/E ratio	16.05●	40.25
Forward P/E	9.31●	25.41
P/S ratio	2.41●	14.05
P/B ratio	5.82●	32.54
PEG ratio	1.71	0.49●
EV / EBITDA	11.03●	31.47
FCF yield	10.20%●	1.34%

Profitability

Metric	BMY	LLY
Gross margin	68.75%	83.51%●
Operating margin	25.67%	45.87%●
Net margin	15.01%	34.98%●
ROE	36.25%	81.01%●
ROIC	13.90%	30.20%●

Dividends

Metric	BMY	LLY
Dividend yield	4.38%●	0.57%
Payout ratio	72.25%	28.09%

Growth (annualized)

Metric	BMY	LLY
Revenue CAGR (5Y)	2.52%	23.17%●
EPS CAGR (5Y)	9.38%	28.88%●
FCF CAGR (5Y)	-2.50%	19.54%●
Total return CAGR (5Y)	0.74%	39.57%●

Frequently asked

Which is better, BMY or LLY?: It depends on your goal. value: BMY (lower P/E); growth: LLY (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: LLY (higher ROIC). Across all compared metrics, LLY leads 10 to 7.
Is BMY or LLY cheaper?: On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and LLY at 40.25.
Which has grown faster, BMY or LLY?: Over the past five years, LLY grew revenue faster — BMY at a 2.52% CAGR versus LLY at 23.17%.
Does BMY or LLY pay a bigger dividend?: BMY yields 4.38% and LLY yields 0.57% based on trailing dividends and the latest price.
Is BMY or LLY more profitable?: LLY runs the higher net margin — BMY at 15.01% versus LLY at 34.98%.
Which has been the better investment, BMY or LLY?: Over the past 10-year, LLY delivered the higher annualized total return — BMY at 1.08% versus LLY at 33.50%. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full LLY analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Eli Lilly and P/E ratio Bristol-Myers Squibb dividend yield Eli Lilly and dividend yield Bristol-Myers Squibb ROE Eli Lilly and ROE Bristol-Myers Squibb operating margin Eli Lilly and operating margin Bristol-Myers Squibb revenue growth Eli Lilly and revenue growth Bristol-Myers Squibb free cash flow Eli Lilly and free cash flow

Bristol-Myers Squibb & Eli Lilly and appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.